scholarly article | Q13442814 |
P356 | DOI | 10.1002/1521-2254(2000)9999:9999<::AID-JGM152>3.0.CO;2-U |
P698 | PubMed publication ID | 11269337 |
P2093 | author name string | Vega M | |
Danos O | |||
Jenny C | |||
Vincent N | |||
Drittanti L | |||
Manceau P | |||
Poulard K | |||
Samba A | |||
Soria N | |||
P2860 | cites work | Real time quantitative PCR | Q29616373 |
Selective and rapid uptake of adeno-associated virus type 2 in brain | Q34471578 | ||
Adeno-associated virus vectors can be efficiently produced without helper virus | Q34479933 | ||
Widespread long-term gene transfer to mouse skeletal muscles and heart | Q35605664 | ||
Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus | Q36159178 | ||
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina | Q36439639 | ||
High throughput production, screening and analysis of adeno-associated viral vectors | Q40874832 | ||
High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. | Q40933793 | ||
High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus | Q40992577 | ||
Factors influencing recombinant adeno-associated virus production | Q41049528 | ||
A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease | Q41192401 | ||
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. | Q41722852 | ||
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector | Q43783192 | ||
Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice | Q44678756 | ||
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors | Q45299117 | ||
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system | Q45747815 | ||
Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses | Q45749766 | ||
Novel tools for production and purification of recombinant adenoassociated virus vectors | Q45752072 | ||
Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. | Q48169737 | ||
The kinetics of rAAV integration in the liver | Q74557678 | ||
P433 | issue | 1 | |
P921 | main subject | vector-borne disease | Q2083837 |
P304 | page(s) | 59-71 | |
P577 | publication date | 2001-01-01 | |
P1433 | published in | Journal of Gene Medicine | Q15746377 |
P1476 | title | Optimised helper virus-free production of high-quality adeno-associated virus vectors | |
P478 | volume | 3 |
Q39685433 | A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines |
Q58795206 | AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6 |
Q39686372 | Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production |
Q35216648 | Adeno-associated viral vectors. |
Q42030992 | C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice |
Q36288920 | Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications |
Q39729376 | DNA affects the composition of lipoplex protein corona: a proteomics approach |
Q47626470 | DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice |
Q40697742 | Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic beta-globin in cultured murine fibroblasts |
Q30462040 | Evaluation of a Serum-free Medium for the Production of rAAV-2 using HeLa Derived Producer Cells |
Q38112216 | Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease |
Q33763673 | Gene therapy targeting glaucoma: where are we? |
Q34447817 | Hot topics in adeno-associated virus as a gene transfer vector |
Q40269728 | Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors |
Q45414317 | Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways |
Q45858769 | Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage |
Q35061706 | Non-viral gene delivery in skeletal muscle: a protein factory |
Q39062624 | Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery |
Q40672137 | Quantification of adeno-associated virus particles and empty capsids by optical density measurement |
Q37092798 | Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions |
Q37479802 | Transient transfection methods for clinical adeno-associated viral vector production |